Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis.
Yahagi K, Kolodgie FD, Otsuka F, Finn AV, Davis HR, Joner M, Virmani R.
Nat Rev Cardiol. 2016 Feb;13(2):79-98. doi: 10.1038/nrcardio.2015.164. Epub 2015 Oct 27.
Saphenous Vein Graft Aneurysm after Drug-Eluting Stent Implantation: Treatment by Covered Stent.
Papadopoulos K, Avraamides P.
Case Rep Cardiol. 2021 Nov 5;2021:2360804. doi: 10.1155/2021/2360804. eCollection 2021.
Use of drug-eluting stents in saphenous vein aortocoronary bypass graft lesions: a critical appraisal.
Brilakis ES, Saeed B, Banerjee S.
J Interv Cardiol. 2008 Apr;21(2):151-7. doi: 10.1111/j.1540-8183.2007.00341.x. Epub 2008 Feb 28.
Long-Term Results After Drug-Eluting Versus Bare-Metal Stent Implantation in Saphenous Vein Grafts: Randomized Controlled Trial.
Fahrni G, Farah A, Engstrøm T, Galatius S, Eberli F, Rickenbacher P, Conen D, Mueller C, Pfister O, Twerenbold R, Coslovsky M, Cattaneo M, Kaiser C, Mangner N, Schuler G, Pfisterer M, Möbius-Winkler S, Jeger RV; BASKET‐SAVAGE‐Investigators*.
J Am Heart Assoc. 2020 Oct 20;9(20):e017434. doi: 10.1161/JAHA.120.017434. Epub 2020 Oct 9.
Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial.
Mehilli J, Pache J, Abdel-Wahab M, Schulz S, Byrne RA, Tiroch K, Hausleiter J, Seyfarth M, Ott I, Ibrahim T, Fusaro M, Laugwitz KL, Massberg S, Neumann FJ, Richardt G, Schömig A, Kastrati A; Is Drug-Eluting-Stenting Associated with Improved Results in Coronary Artery Bypass Grafts? (ISAR-CABG) Investigators.
Lancet. 2011 Sep 17;378(9796):1071-8. doi: 10.1016/S0140-6736(11)61255-5. Epub 2011 Aug 26.
Three-Year Clinical and Angiographic Outcomes After Everolimus-Eluting Stent Implantation in Patients With a History of Coronary Artery Bypass Grafting.
Nomura T, Suzuki N, Takamura S, Kyono H, Kozuma K.
Int Heart J. 2016;57(2):158-66. doi: 10.1536/ihj.15-312. Epub 2016 Mar 11.
Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
Harskamp RE, Beijk MA, Damman P, Kuijt WJ, Woudstra P, Grundeken MJ, Kloek JJ, Tijssen JG, de Mol BA, de Winter RJ.
J Cardiovasc Med (Hagerstown). 2013 Jun;14(6):438-45. doi: 10.2459/JCM.0b013e328356a4fc.
Drug-eluting Vein Graft with Acetylsalicylic Acid-Ticagrelor-Unfractionated Heparin Complex Inhibits Early Graft Thrombosis.
Akşit E, Kurt T, Büyük B, Çokkalender Ö.
Balkan Med J. 2020 Aug 11;37(5):269-275. doi: 10.4274/balkanmedj.galenos.2020.2020.1.128. Epub 2020 May 1.
Comparison of diagnostic accuracy of immediate angiography derived residual quantitative flow ratio after bioresorbable scaffold and drug eluting stent implantation.
Li Z, Zhan J, Han J, Fu G, Jin C.
Rev Cardiovasc Med. 2022 Feb 12;23(2):59. doi: 10.31083/j.rcm2302059.
Complete fracture of sirolimus-eluting stent in a saphenous vein graft to left anterior descending artery.
Yoo SH, Jin SW, Her SH, Yoon HJ, Kim HD, Im YS, Seung KB, Kim JH.
Korean Circ J. 2009 Jun;39(6):251-3. doi: 10.4070/kcj.2009.39.6.251. Epub 2009 Jun 30.
